🇺🇸 FDA
Patent

US 9895414

Inhibition of cancer growth and metastasis

granted A61KA61K2039/505A61K31/7105

Quick answer

US patent 9895414 (Inhibition of cancer growth and metastasis) held by ABREGEN PTY LTD expires Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ABREGEN PTY LTD
Grant date
Tue Feb 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K2039/505, A61K31/7105, A61K31/713, A61K38/1709